Stephen Kidd, MD
Interventional Cardiology · Saint Cloud, MNNPI 1477816304
Payments from drug & device makers
Across 742 payments — averaging $874.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$251K
- Edwards Lifesciences$186K
- Boston Scientific$101K
- Medtronic$47K
- Shockwave Medical, Inc$19K
- Canon Medical Informatics, Inc.$17K
- plus $28K from 21 others
Across 6 payments — averaging $61.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$371
What the payments were for
- Consulting fees$154,19525%
- Speaking & faculty fees$394,62365%
- Travel & lodging$38,2896%
- Food & beverage$20,0613%
- Education$1970%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 168 | $250,595 |
| Edwards Lifesciences | 221 | $185,512 |
| Boston Scientific | 151 | $101,496 |
| Medtronic(2 entities) | 96 | $47,042 |
| Shockwave Medical, Inc | 11 | $18,994 |
| Canon Medical Informatics, Inc. | 3 | $16,850 |
| Cardiovascular Systems Inc. | 25 | $15,482 |
| Abbott | 25 | $11,220 |
| Inari Medical, Inc. | 5 | $304 |
| Inquis Medical, Inc. | 4 | $279 |
| Angiodynamics, Inc. | 5 | $259 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $180 |
| Penumbra, Inc. | 2 | $130 |
| Cardiac Dimensions, Inc. | 3 | $130 |
| AstraZeneca | 2 | $113 |
| Reflow Medical Inc | 1 | $81 |
| Terumo Medical Corporation | 4 | $72 |
| Asahi Intecc USA, Inc. | 2 | $35 |
| Cordis US CORP. | 2 | $31 |
| Philips North America LLC | 1 | $29 |
| Biotronik Inc. | 1 | $28 |
| Heartflow, Inc. | 1 | $25 |
| Cathworks, Inc. | 1 | $22 |
| Novartis | 1 | $18 |
| Teleflex LLC | 1 | $15 |
| Livanova USA, Inc. | 1 | $15 |
| Corindus Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$222,862
- PASCAL$95,968
- Edwards SAPIEN 3 Transcatheter Heart Valve$54,141
- Sentinel$50,313
- Diamondback Coronary$24,653
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$18,969
- General - CT_IC$12,500
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$10,515
- GENERAL VASCULAR ACCESS$9,375
- GENERAL BALLOONS$7,500
- GENERAL - THERAPIES$5,999
- AVVIGO Guidance System$5,378
- Vitrea AV TAVR$4,999
- COREVALVE EVOLUT R$3,310
- EVOQUE$1,952
- Vitalyst$1,250
- SAPIEN 3 Ultra RESILIA$1,050
- MitraClip System$384
- CROSSBOSS$221
- Telescope$158
How this compares
$648,969 in reported general payments places this provider in the 90th percentile of 84 interventional cardiology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 138 | $121,755 |
| JardianceEmpagliflozin | 22 | $35,780 |
| Repatha SureclickEvolocumab | 14 | $21,022 |
| EntrestoSacubitril/Valsartan | 11 | $19,941 |
| XareltoRivaroxaban | 14 | $19,512 |
| Metoprolol Succinate | 139 | $2,373 |
| Atorvastatin Calcium | 136 | $1,636 |
| ClopidogrelClopidogrel Bisulfate | 108 | $1,580 |
| Rosuvastatin Calcium | 64 | $1,250 |
| Losartan Potassium | 97 | $983 |
| Flecainide Acetate | 12 | $924 |
| Amlodipine Besylate | 60 | $904 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 39 | $792 |
| Pantoprazole Sodium | 41 | $703 |
| Lisinopril | 66 | $668 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $18 | $19,94111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 84 interventional cardiology providers in Minnesota.
Other interventional cardiology in Saint Cloud
- Thom DahleSaint Cloud$2.2M
- Juliette PowerSaint Cloud$4K
- Brian StegmanSt Cloud$2.3M
- Emmanouil BrilakisMinneapolis$2.2M
- Trevor SimardRochester$1.6M
- Jacob DutcherSt Cloud$1.1M
- Gregory HelmerEdina$828K
- Yale WangMinneapolis$725K
- Ivan ChavezMinneapolis$539K
- Wesley PedersenMinneapolis$517K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.